Space Asset Acquisition Corp. listed on Nasdaq in January 2026 with roughly $230 million in trust. The sponsor is Raphael Roettgen, an ex-investment banker who abandoned a space-focused SPAC in 2022 when the blank-check market for space collapsed. He is back. He is not the only one. A lot of us wrote the space SPAC off two years ago as structurally broken. It is structurally unchanged. It is also reappearing.
There is a real change in the target pool. In 2021, most space SPAC targets were pre-revenue concept companies valued on 2028 projections. A cohort of defense-adjacent space companies now has revenue, government customers, and unit economics that did not exist five years ago. That cohort is not, for the most part, the cohort choosing SPACs. Good companies do traditional IPOs. An S-1 is a harder document to write than a de-SPAC proxy, and that is the point. The discipline required to survive S-1 review is part of what builds durable investor trust on the other side. Companies that elect the SPAC path are telling you something about the traditional path they declined.
What has not changed is the structure of the vehicle. A SPAC is a compromised way to take a company public. The sponsor earns a promoted return regardless of whether the deal performs. The trust runs a clock — typically 18 to 24 months — that pressures the sponsor to find a target whether or not the right target exists. The merger vote and the redemption right are structurally separated, which means the people approving the deal and the people taking cash off the table are often not the same people. And forward-looking statements in a de-SPAC proxy are protected by a safe harbor that does not apply to a traditional S-1. The projections carry less legal risk in a SPAC. They also carry less scrutiny.
A USSF supplier that walks through the de-SPAC door discloses material about future contract revenue, margin structure, and capability milestones that is almost always more aggressive than what the same company would put in an S-1. The forward projections become the story. The forward projections become the stock price. The forward projections become the pressure a newly public company faces every ninety days.
Four questions before you trust a de-SPAC'd supplier
Sponsor track record. Has this sponsor taken a company public before? What happened after? A sponsor whose prior deal is trading at twenty cents on the dollar is not the same as one with a book of completed, still-intact deals. Trust and PIPE composition. A PIPE anchored by defense primes, sovereign wealth, and committed long-term capital signals one thing. A PIPE filled with crossover hedge funds and retail vehicles signals another. Target readiness for public-company cadence. Does the CFO have public-company experience? Are SOX controls in place now — not slated for after close? A company that has never published audited quarterly financials is not ready for the first one in ninety days. Use of proceeds. Is the cash funding product, manufacturing, and delivery against contracted backlog — or is a meaningful share flowing to insider secondary, sponsor promote, and advisor fees? Read the proxy.
The Build section below walks through each of these four questions in depth.
The forensic read is that the wrapper choice is itself part of the signal. A company with eighteen months of contracted revenue, a Tier 1-or-2 cap table, audited financials, and a CFO who has filed a 10-K before can raise at a fair mark in a traditional IPO. When that same company chooses a SPAC instead, something else is in the trade — a valuation the public market would not give it on its own, a timeline that will not survive a roadshow, or a disclosure posture that would not survive an S-1's liability regime. The companies using SPACs well are the exception. The rule is that good companies do traditional IPOs.
For acquisition officers, here is what changes. A supplier that becomes a public company now has to disclose material changes in customer concentration, contract losses, cyber incidents, export-control exposure, and executive departures on fast reporting timelines. That is useful intelligence when the architecture depends on continued delivery from that supplier. It is also the beginning of quarterly earnings pressure. Programs that rely on steady capability maturation do not always survive contact with a public-market shareholder base that wants top-line growth every ninety days. Both things are true at once.
The SPAC window is open. That alone is a warning. A supplier choosing a de-SPAC over a traditional IPO is making a statement about the road it did not walk. The Financial Confidence Level framework (covered in Issue 003) applies either way — and the wrapper choice is now part of the diligence file, not outside it. Read the company. Read the wrapper. Both.
